×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS ...
PR Newswire
PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has...
2 months ago
BioVaxys Acquires Full Portfolio of Former IMV
PharmTech
BioVaxys has acquired the full portfolio of discovery, preclinical, and clinical development-stage assets of the former IMV.
2 months ago
IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets
Business Wire
IMV Inc. (the “Company” or “IMV”) announces today that it has accepted an offer (the “Offer”) from IMV's largest secured creditors (the...
8 months ago
BioVaxys snatches up 'bankrupt' IMV's preclinical and clinical assets
Pharmaceutical Technology
BioVaxys will pay $750,000 in upfront payments, along with milestone-based payments and royalties on licensing revenue and product sales.
2 months ago
IMV (IMVIQ) EPS without NRI : $-4.55 (TTM As of Dec. 2022)
GuruFocus
IMV (IMVIQ) EPS without NRI as of today (May 03, 2024) is $-4.55. EPS without NRI explanation, calculation, historical data and more.
4 days ago
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the ...
Canada Newswire
CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has executed the...
2 months ago
BioVaxys acquires IMV's immunotherapy assets and IP By Investing.com
Investing.com
VANCOUVER - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) has completed an asset purchase agreement to acquire the...
2 months ago
IMV (TSE:IMV) Shares Down 1.8%
Defense World
IMV Inc. (TSE:IMV – Get Free Report) shares fell 1.8% during trading on Monday . The company traded as low as C$1.07 and last traded at...
1 week ago
BioVaxys Receives Cease Trade Order Amid Audit Delays - TipRanks.com
Tipranks
Biovaxys Technology Corp (TSE:BIOV) has released an update. BioVaxys Technology Corp. has received a management cease trade order due to a delay in filing...
2 months ago
IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process
Business Wire
IMV Inc. (the “Company” or “IMV”), recently announced an update on the Sales and Investment Solicitation Process (the “SISP”) implemented as...
9 months ago